Time to chronic PA · children (aged 1 to 12 years) with CF and a newly isolated PA infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: severe adverse events (total) · children (aged 1 to 12 years) with CF and a newly isolated PA infection
Summary of findings: cycled showed no clear difference in adverse events: severe adverse events (total) compared with culture‐based antibiotic therapy (moderate certainty).
1 finding from 1 review
Emergence of novel bacteria: isolation of novel gram negative organisms · children (aged 1 to 12 years) with CF and a newly isolated PA infection
Summary of findings: cycled showed no clear difference in emergence of novel bacteria: isolation of novel gram negative… compared with culture‐based antibiotic therapy (moderate certainty).
1 finding from 1 review
Time to bladder cancer recurrence (absolute effect size estimates based on recurrence rate at 12 months)
Single‐dose intravesical chemotherapy instillation may leads to lower time to bladder cancer recurrence (absolute effect size estimates… compared with placebo or observation after nephroureterectomy (low certainty).
1 finding from 1 review
Time to death from UTUC5
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events
1 finding from 1 review
Time to death from any cause5
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease‐specific quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival (absolute effect size estimates based on survival rate at 24 months) · Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)Country:…
Impact of extended showed no clear difference in time to death from any cause (absolute effect size estimates based… compared with standard lymph node dissection on overall survival among patients… (low certainty).
1 finding from 1 review
Time to death from bladder cancer · Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)Country:…
Impact of extended showed no clear difference in time to death from bladder cancer (absolute effect size estimates… compared with standard lymph node dissection on overall survival among patients… (low certainty).
1 finding from 1 review
Clavien‐Dindo grade ≥ 3 complications · Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)Country:…
It is very uncertain whether impact of extended changes clavien‐Dindo grade ≥ 3 complications compared with standard lymph node dissection on overall survival among patients… (very low certainty).
1 finding from 1 review
Time to recurrence · Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)Country:…
It is very uncertain whether impact of extended changes time to recurrence (absolute effect size estimates based on… compared with standard lymph node dissection on overall survival among patients… (very low certainty).
1 finding from 1 review
Clavien‐Dindo grade ≤ 2 complications8 · Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)Country:…
It is very uncertain whether impact of extended changes clavien‐Dindo grade ≤ 2 complications8 compared with standard lymph node dissection on overall survival among patients… (very low certainty).
1 finding from 1 review
Disease‐specific quality of life · Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)Country:…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Tardive dyskinesia: Not improved to a clinically important extent · patients with antipsychotic‐induced TD
The intervention may leads to lower tardive dyskinesia: Not improved to a clinically important extent (low certainty).
1 finding from 1 review
Intervention not reported
Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes tardive dyskinesia: Deterioration of symptoms (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Mental state: Deterioration · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes mental state: Deterioration (very low certainty).
1 finding from 1 review
Intervention not reported
Acceptability of treatment: Leaving the study early · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes acceptability of treatment: Leaving the study early (very low certainty).
1 finding from 1 review
Intervention not reported
Social confidence, social inclusion, social networks, or personalised quality of life measures · patients with antipsychotic‐induced TD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found